Incannex Healthcare (IXHL) Other Non-Current Liabilities (2020 - 2026)
Incannex Healthcare (IXHL) posted quarterly Other Non-Current Liabilities of $3.1 million for Q1 2026, up 132.98% year-on-year from $1.3 million in Q1 2025, and up 132.98% on a QoQ basis from $1.3 million in Q1 2025.
Incannex Healthcare (IXHL) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Incannex Healthcare (IXHL) has reported Other Non-Current Liabilities for 4 consecutive years, with $3.1 million the latest figure, recorded in Q1 2026.
- Quarterly Other Non-Current Liabilities rose 132.98% year-over-year to $3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 million (up 132.98% YoY) and the FY2020 annual result came in at $116645.0, changed N/A from the prior year.
- Other Non-Current Liabilities rose to $3.1 million in Q1 2026 per IXHL's latest filing, from $1.3 million in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for IXHL reached as high as $3.1 million in Q1 2026 and fell as low as $1.3 million in Q4 2024.
- A 3-year average of $1.9 million and a median of $1.3 million in 2025 frame the typical range for Other Non-Current Liabilities.
- The largest YoY upside for Other Non-Current Liabilities was 132.98% in 2026 against a maximum downside of 132.98% in 2026.
- Year by year, Other Non-Current Liabilities stood at $1.3 million in 2024, then grew by 2.8% to $1.3 million in 2025, then surged by 132.98% to $3.1 million in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $3.1 million, $1.3 million, and $1.3 million for Q1 2026, Q1 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Incannex Healthcare | 3.63 Mn | 3.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.08 Mn |
| Mar 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | 1.29 Mn |
| Jun 30, 2020 | 116,645.00 |